Chembio HIV test
This article was originally published in The Tan Sheet
Executive Summary
Chembio announces a new method for performing its HIV 1/2 STAT-PAK Dipstick test during the International AIDS Conference in Toronto, Canada. The new procedure involves placing the test strip on a flat laminate card like a "standard cassette test, yet without the cost and weight of cassette components," the company states in an Aug. 15 release. Customers can still use the original tube procedure as an alternate testing method. Chembio is moving closer toward OTC HIV tests since it filed a CLIA waiver application in July that allows the firm to market its tests to physician offices, clinics and other public health venues. HIV STAT-PAK Dipstick is not yet FDA-approved. Chembio received approval for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK tests in May 1("The Tan Sheet" June 5, 2006, p. 3)...
You may also be interested in...
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.